NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

Kim CW, Jung TY, Kim C, Kim E, Kim HO, Chae J, Kim H, Ko GY, Yeo YJ, Park JY, Pyo J, Seo JT, Kim D, Park J, Kim SJ, An M, Kang SG, Park JB, Kim CH, Jung SH, Lee SH, Kim HS, Kim HS

Open source

DOI: 10.1038/s12276-026-01818-9
Published: 2026 Sep 2
Container: Experimental & molecular medicine
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s12276-026-01818-9,
  title = {NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.},
  author = {Kim CW and Jung TY and Kim C and Kim E and Kim HO and Chae J and Kim H and Ko GY and Yeo YJ and Park JY and Pyo J and Seo JT and Kim D and Park J and Kim SJ and An M and Kang SG and Park JB and Kim CH and Jung SH and Lee SH and Kim HS and Kim HS},
  year = {2026},
  journal = {Experimental \& molecular medicine},
  doi = {10.1038/s12276-026-01818-9},
  url = {https://doi.org/10.1038/s12276-026-01818-9}
}

RIS

TY  - JOUR
TI  - NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.
AU  - Kim CW
AU  - Jung TY
AU  - Kim C
AU  - Kim E
AU  - Kim HO
AU  - Chae J
AU  - Kim H
AU  - Ko GY
AU  - Yeo YJ
AU  - Park JY
AU  - Pyo J
AU  - Seo JT
AU  - Kim D
AU  - Park J
AU  - Kim SJ
AU  - An M
AU  - Kang SG
AU  - Park JB
AU  - Kim CH
AU  - Jung SH
AU  - Lee SH
AU  - Kim HS
AU  - Kim HS
PY  - 2026
JO  - Experimental & molecular medicine
DO  - 10.1038/s12276-026-01818-9
UR  - https://doi.org/10.1038/s12276-026-01818-9
ER  -

APA

CW, K., TY, J., C, K., E, K., HO, K., J, C., H, K., GY, K., YJ, Y., JY, P., J, P., JT, S., D, K., J, P., SJ, K., M, A., SG, K., JB, P., CH, K., SH, J., SH, L., HS, K., & HS, K. (2026). NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.. Experimental & molecular medicine. https://doi.org/10.1038/s12276-026-01818-9

Source records

pubmed · retrieved 2026-09-26T10:39:38.532Z
europe-pmc · retrieved 2026-09-26T10:39:38.535Z